Cargando…

In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals

Caralluma europaea (Guss.) N.E.Br. (C. europaea), is a medicinal plant used traditionally to treat diabetes mellitus (DM) in Morocco. This study aimed to investigate the in vitro antioxidant properties, glucose diffusion effects, α-amylase inhibitory activity, and pancreatic protective effects of C....

Descripción completa

Detalles Bibliográficos
Autores principales: Ouassou, Hayat, Bouhrim, Mohamed, Bencheikh, Noureddine, Addi, Mohamed, Hano, Christophe, Mekhfi, Hassane, Ziyyat, Abderrahim, Legssyer, Abdekhaleq, Aziz, Mohamed, Bnouham, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614910/
https://www.ncbi.nlm.nih.gov/pubmed/34829618
http://dx.doi.org/10.3390/antiox10111747
_version_ 1784603975619706880
author Ouassou, Hayat
Bouhrim, Mohamed
Bencheikh, Noureddine
Addi, Mohamed
Hano, Christophe
Mekhfi, Hassane
Ziyyat, Abderrahim
Legssyer, Abdekhaleq
Aziz, Mohamed
Bnouham, Mohamed
author_facet Ouassou, Hayat
Bouhrim, Mohamed
Bencheikh, Noureddine
Addi, Mohamed
Hano, Christophe
Mekhfi, Hassane
Ziyyat, Abderrahim
Legssyer, Abdekhaleq
Aziz, Mohamed
Bnouham, Mohamed
author_sort Ouassou, Hayat
collection PubMed
description Caralluma europaea (Guss.) N.E.Br. (C. europaea), is a medicinal plant used traditionally to treat diabetes mellitus (DM) in Morocco. This study aimed to investigate the in vitro antioxidant properties, glucose diffusion effects, α-amylase inhibitory activity, and pancreatic protective effects of C. europaea in experimental alloxan-induced diabetes in mice. Total phenolic contents were determined by Folin–Ciocalteu colorimetric method, total flavonoid contents were measured by aluminum chloride colorimetric assay, and tannins contents were determined by employing the vanillin method. C. europaea ethyl acetate fraction exhibited high antioxidant potential in terms of radical scavenging (DPPH) (IC50 = 0.22 ± 0.01 mg/mL), β-carotene bleaching activity (IC50 = 1.153 ± 0.07 mg/mL), and Ferric-reducing antioxidant power. Glucose diffusion was significantly inhibited by the ethyl acetate fraction at 60,120and 180 min, while the aqueous extract did not have this inhibitory effect when compared with the control group. Potent α-amylase inhibitory activity was observed in the ethyl acetate fraction and the aqueous extract in vitro and in vivo using STZ-diabetic rats. On the other hand, the administration of the ethyl acetate fraction (60 mg/kg) significantly attenuated alloxan-induced death and hyperglycemia in treated mice. Furthermore, histopathological investigations revealed that the ethyl acetate fraction protected islets of Langerhans against alloxan-induced tissue alterations. These results suggest that C. europaea exhibited an important antihyperglycemic effect via the inhibition of glucose diffusion and pancreatic α-amylase activity. In addition, the antidiabetogenic effect of C. europaea might be attributed to their polyphenol and flavonoid compounds, which could be reacted alone, or in synergy, to scavenge the free radicals produced by the alloxan.
format Online
Article
Text
id pubmed-8614910
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86149102021-11-26 In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals Ouassou, Hayat Bouhrim, Mohamed Bencheikh, Noureddine Addi, Mohamed Hano, Christophe Mekhfi, Hassane Ziyyat, Abderrahim Legssyer, Abdekhaleq Aziz, Mohamed Bnouham, Mohamed Antioxidants (Basel) Article Caralluma europaea (Guss.) N.E.Br. (C. europaea), is a medicinal plant used traditionally to treat diabetes mellitus (DM) in Morocco. This study aimed to investigate the in vitro antioxidant properties, glucose diffusion effects, α-amylase inhibitory activity, and pancreatic protective effects of C. europaea in experimental alloxan-induced diabetes in mice. Total phenolic contents were determined by Folin–Ciocalteu colorimetric method, total flavonoid contents were measured by aluminum chloride colorimetric assay, and tannins contents were determined by employing the vanillin method. C. europaea ethyl acetate fraction exhibited high antioxidant potential in terms of radical scavenging (DPPH) (IC50 = 0.22 ± 0.01 mg/mL), β-carotene bleaching activity (IC50 = 1.153 ± 0.07 mg/mL), and Ferric-reducing antioxidant power. Glucose diffusion was significantly inhibited by the ethyl acetate fraction at 60,120and 180 min, while the aqueous extract did not have this inhibitory effect when compared with the control group. Potent α-amylase inhibitory activity was observed in the ethyl acetate fraction and the aqueous extract in vitro and in vivo using STZ-diabetic rats. On the other hand, the administration of the ethyl acetate fraction (60 mg/kg) significantly attenuated alloxan-induced death and hyperglycemia in treated mice. Furthermore, histopathological investigations revealed that the ethyl acetate fraction protected islets of Langerhans against alloxan-induced tissue alterations. These results suggest that C. europaea exhibited an important antihyperglycemic effect via the inhibition of glucose diffusion and pancreatic α-amylase activity. In addition, the antidiabetogenic effect of C. europaea might be attributed to their polyphenol and flavonoid compounds, which could be reacted alone, or in synergy, to scavenge the free radicals produced by the alloxan. MDPI 2021-10-31 /pmc/articles/PMC8614910/ /pubmed/34829618 http://dx.doi.org/10.3390/antiox10111747 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ouassou, Hayat
Bouhrim, Mohamed
Bencheikh, Noureddine
Addi, Mohamed
Hano, Christophe
Mekhfi, Hassane
Ziyyat, Abderrahim
Legssyer, Abdekhaleq
Aziz, Mohamed
Bnouham, Mohamed
In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals
title In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals
title_full In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals
title_fullStr In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals
title_full_unstemmed In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals
title_short In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects of C. Europaea Extracts in Experimental Animals
title_sort in vitro antioxidant properties, glucose-diffusion effects, α-amylase inhibitory activity, and antidiabetogenic effects of c. europaea extracts in experimental animals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614910/
https://www.ncbi.nlm.nih.gov/pubmed/34829618
http://dx.doi.org/10.3390/antiox10111747
work_keys_str_mv AT ouassouhayat invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT bouhrimmohamed invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT bencheikhnoureddine invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT addimohamed invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT hanochristophe invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT mekhfihassane invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT ziyyatabderrahim invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT legssyerabdekhaleq invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT azizmohamed invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals
AT bnouhammohamed invitroantioxidantpropertiesglucosediffusioneffectsaamylaseinhibitoryactivityandantidiabetogeniceffectsofceuropaeaextractsinexperimentalanimals